| Serial Number | 98256507 |
| Word Mark | ACCESS DAXXIFY |
| Filing Date | Monday, November 6, 2023 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, October 29, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, September 3, 2024 |
| Description of Mark | The mark consists of the words "ACCESS" in lower case, stylized letters and "DAXXIFY" in stylized capital letters. The word "ACCESS" is within a parallelogram design which appears to the left of the word "DAXXIFY". There are two arrows that form a partial circle. The upper arrow begins at the first letter "S" in the word "ACCESS" and connects to the letter "A" in the word "DAXXIFY". The lower arrow begins at the letter "A" in the word "DAXXIFY" and connects to the first letter "S" in the word "ACCESS". |
| Goods and Services | Financial management of patient reimbursement programs; Financial administration of medication reimbursement programs; Providing patient financial support services, namely, providing insurance information to help patients understand their insurance and plan benefits, providing insurance claims processing information in the nature of information about insurance authorization forms and appeals, and providing insurance reimbursement assistance to eligible patients in the nature of reimbursement payment processing in the field of health and pharmaceutical insurance claims |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| International Class | 036 - Insurance; financial affairs; monetary affairs; real estate affairs. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, December 2, 2023 |
| Primary Code | 036 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Revance Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Newark, CA 94560 |
| Party Name | Revance Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Newark, CA 94560 |
| Event Date | Event Description |
| Thursday, November 9, 2023 | NEW APPLICATION ENTERED |
| Tuesday, December 5, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Saturday, December 2, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, June 14, 2024 | ASSIGNED TO EXAMINER |
| Monday, June 17, 2024 | NON-FINAL ACTION E-MAILED |
| Monday, June 17, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, June 17, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, June 27, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, June 27, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, June 27, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, July 31, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 14, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 3, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 3, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 29, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |